Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2025.Oct.20

Announcement to creditors of the Company for conducting capital reduction to make up for losses.

2025.Oct.20

Announcement of the Company’s important resolutions of the 2025 First Extraordinary General Shareholders’ meeting.

2025.Oct.17

Announcement on behalf of OBIGEN that it obtains the Internal Control Special Audit Report by CPA

2025.Oct.02

Announcement on behalf of Obigen’s BOD to resolve the reference date for conversion of employee stock options to common shares

2025.Sep.01

Press Conference on Material Information Regarding the Board Resolution for Capital Reduction to Offset Accumulated Losses

2025.Sep.01

The Company’s Board of Directors resolved to conduct a capital reduction to offset accumulated losses.

2025.Sep.01

The Company’s Board of Directors resolved to convene the 2025 first extraordinary general shareholders’ meeting

2025.Aug.26

Announcement for OBIGEN that its Phase 2 study for OBI-858 received positive final results and met primary and secondary endpoints with statistical significance

2025.Aug.22

Announcement on behalf of OBIGEN:TFDA Approves IND application for Two Pivotal Phase III Studies of OBI-858

2025.Aug.11

Announcement of the Consolidated Financial Statements for the second quarter of 2025 were approved by the Board of Directors

News

Latest News

Events

Latest events